Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture.

This week, Anne Donohoe sat down with James Krouse, CEO of Flower Power Genetics, to talk about how his company is working to preserve and reintroduce the best purebred medicinal cannabis strains into the marketplace. James walked our host through his past 30 years of work including how he has painstakingly researched, collected and preserved original Nevil medical seeds, dating back to the golden age of cannabis in the late 1980s and 1990s. James also touches on the medicinal benefits of these original strains, feedback he’s received from the industry and how rescheduling will allow for more research opportunities for his group. 

If you are interested in learning more about James or Flower Power, you can follow them across social channels and visit the links found in our show notes. 

So, sit back and enjoy our conversation with James Krouse, CEO of Flower Power Genetics. 

Links, mentions, and socials:

Flower Power Website: https://flowerpowergenetics.com/James’ LinkedIn: https://www.linkedin.com/in/james-krouse-fpg/ Utility Patent Announcement: https://mgmagazine.com/press-releases/flower-power-genetics-secures-pending-utility-patent-for-hybrid-adam/ 

Show Credits:

This episode was hosted by Anne Donohoe of KCSA Strategic Communications. 

Special thanks to our Program Director, Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:

X: @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: linkedin.com/company/thegreenrushpodcast

Facebook: facebook.com/TheGreenRushPodcast 

YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true